cefadroxil capsules, USP
DESCRIPTION
Cefadroxil capsules contain the following inactive ingredients: Lactose monohydrate, magnesium stearate, FD&C Blue No.1, D&C Red No.28, FD&C Red No. 40, titanium dioxide, gelatin, sodium lauryl sulphate, and edible black ink (black iron oxide).
CLINICAL PHARMACOLOGY
| Zone diameter (mm) | Interpretation |
| ≥ 1815–17≤ 14 | (S) Susceptible(I) Intermediate(R) Resistant |
| Organism | Zone Diameter (mm) |
| Staphylococcus aureus ATCC 25923 Escherichia coli ATCC 25922 | 29–3717–22 |
INDICATIONS AND USAGE
CONTRAINDICATIONS
WARNINGS
PRECAUTIONS
General
Information for Patients
Drug/Laboratory Test Interactions
Carcinogenesis, Mutagenesis, Impairment of Fertility
Pregnancy
Labor and Delivery
Nursing Mothers
Pediatric Use
Geriatric Use
ADVERSE REACTIONS
OVERDOSAGE
DOSAGE AND ADMINISTRATION
Renal Impairment
| Creatinine Clearances | Dosage Interval |
| 0-10 mL/min | 36 hours |
| 10-25 mL/min | 24 hours |
| 25-50 mL/min | 12 hours |
HOW SUPPLIED
REFERENCES
- National Committee for Clinical Laboratory Standards, Approved Standard, Performance Standards for Antimicrobial Disk Susceptibility Test, 4th Edition. Vol. 10 (7): M2-A4, Villanova, PA, April, 1990.
- National Committee for Clinical Laboratory Standards, Approved Standard: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 2nd Edition, Vol. 10(8): M7-A2, Villanova, PA, April, 1990.
PACKAGE LABEL - CEFADROXIL - 500 mg CAPSULES